Altogether, IgE reactivity as tested to 120 allergen components (MeDALL allergen chip), and to M. sympodialis, S. aureus and human epithelial cell extracts (immunoblotting assays) was detected in 92% of patients with severe and 83% of patients with moderate AD (Table 4). This evidence concerns the gene IGHE and Alzheimer disease.